ACM
CRDF icon

Altium Capital Management’s Cardiff Oncology CRDF Stock Holding History

Altium Capital Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-337,000
Closed -$2.02M – 127
2021
Q4 		$2.02M Sell
337,000
-11,888
-3% -$70.9K 0.56% 64
2021
Q3 		$2.32M Sell
348,888
-152,990
-30% -$961K 0.61% 67
2021
Q2 		$3.34M Buy
+501,878
New +$4.26M 0.77% 55
2021
Q1 		– Sell
-185,552
Closed -$3.34M – 130
2020
Q4 		$3.34M Buy
+185,552
New +$3.26M 1.25% 31

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return